1.Results of cardiac electrical stability of Mongolian population of by the method of dispersion visual image electrocardiography
Mongolian Medical Sciences 2018;185(3):59-64
Introduction:
Cardiovascular diseases remains the leading cause of morbidity and mortality in most developed and developing countries. The 34.3% of mortality are due to cardiovascular diseases are in Mongolia. The lifetime risk of cardiovascular disease can be predicted by cardiac electrical instability and arrhythmia findings in ECG. The lack of nationwide data and large multicenter studies in our country do not allow us to estimate the true extend of the problem and we want doing the analysis of the cardiac electrical stability and myocardial index.
Goal:
Evaluate prevalence of cardiac electrical stability and myocardial index of Mongolian people
Material end Methods:
The subjects were recruited from The “Brilliant Hospise” Hospital of Ulaanbaatar, between April 2017 to May 2018. A total of 1000 consecutive patients, aged between 20-70 years were selected. Research was conducted by descriptive research design, anamnesis, anthropometry measurement, laboratory research and was analyzed dispersion visual image ECG. Statistics data was analyzed by SPSS 27 software.
Results:
1000 surveyed aged 20-70 questionnaires, anthropometry measurements, fasting venous blood cholesterol and glucose determined and ECG dispersion visual image sensitive to power quality integrated change and electrical instability of very low frequency change, stimulate the formation and electrical transmission loss, heart disease 23,7% of 610 people surveyed in a relatively healthy and electrical stability of the heart muscle are unchanged, tachycadia, power generation and transmission losses, thickening of the heart muscle, axial deviation, other heart disease due had myocardial electrical instability and changed HRV.
Conclusion
In this study, we demonstrated that prevalence of myocardial electrical instability and myocardial index of relatively healthy people Mongolia. 23,7% of all healthy people changed myocardial electrical instability and HRV. This method that sensitivity of dispersion functions in differentiating norm, premorbid stage and pathologies in many cases in higher than sensitivity of the usual ECG analysis.
2.The risk assessment of atrial fibrillation
Ochirchimeg G ; Ariuntsetseg N
Mongolian Medical Sciences 2018;185(3):54-58
Introduction:
Although we have known for almost last few years that Atrial fibrillation has been increasing by patients in Mongolia. Atrial fibrillation, the most common sustained chronic arrhythmia, with atrial rates of 200-500 beats per minute in patients. Most patients atrial fibrillation have structural heart disease such us mitral stenosis or regurgitation, acute myocardial infarction, Wolff-Parkinson-White syndrome, thyrotoxicosis, recent cardiothoracic surgery, cardiomyopathy, myocarditis or pulmonary disease. Atrial Fibrillation increases the risk of stroke, thromboemboli and mortality of adults with structural heart disease [4]. The symptoms most frequently reported by patients with atrial fibrillation is a rapid, irregullar heartbeat, chest pain, shortness of breath, lightheadedness and dizziness.
Goal:
For that reason we decided to research patients with atrial fibrillation who are treated by the inpatient cardiology department of General hospital of defense and Law Enforcement between 2010-2014 years.
Conclusion
1. The hospitalized patients are observed only 6 cases of atrial fibrillation in 2010 years, even though the prevalence of atrial fibrillation has been increasing 75 cases in 2014 years, as a result it developed 30% during 4 years in hospitalized patients
2. CHA2DS2-VАSc score was high risk of stroke /62.5% of them /most patients with both paroxysmal and chronic atrial fibrillation should be anticoagulated to reduce the occurrence of thromboemboli
3. HAS-BLЕD score has became highest rick of bleeding /32.7% of all patients. For the reason we should be select correctly drugs for patients an anticoagulation treatment and they are controled INR every month
3.Technological study of throat lozenge
Ariuntsetseg A ; Ulambayar L ; Altantuya Ts
Mongolian Pharmacy and Pharmacology 2020;17(2):18-27
In modern days, a phytogenic medicinal form of throat lozenges has been widely used to
treat upper respiratory illnesses such as cough, flu and sore throat.
A medicinal form of lozenge is prepared to have pleasant taste to use for consumers and
it takes up a leading position in pharmaceutical market due to its several advantages. For
instance, the throat lozenge directly influences on oral mucosa and acts partially and generally, increases bioavailability of active substances, and reduces gastric irritation. Moreover,
it is suitable for use and it doesn’t pass through liver. In addition, it is easy to manufacture
and store. The throat lozenge formulation produces mainly a partial therapeutic due to the
additives of various active substances.
Researchers consider that this medicinal form of lozenges is prosperous in pharmaceutical industry and market in near future. Herbal drugs are used as main therapeutic agents
for many diseases due to its market demand. There are many imported herbal drugs used
in Mongolian pharmaceutical market, such as Koflet, Koflet-N, Dr. Mom, Woods, Timiar, and
Linkas. Therefore, it is necessary to study the possibility and prospect of import substitution
industrialization in our home country.
We have conducted a research develop a throat lozenge formulation technology using
medicinal herbs with high-therapeutic value for sore throat treatment. Ural licorice (Glycyrrhiza uralensis Fish), Eugenia caryophyllata Thunb, and Ginger (Kaempferia galangal) were
used in this drug formulation due to their therapeutic effects such as antibacterial, antiviral,
antifungal and anti-inflammation.
The technological phases to prepare throat lozenge were developed on the basis of
method by Suchitra Pundir and Abhay Murari Lal Verma, the scientists at the Department of
Pharmaceutical Management and Technology, Indian University Pharmaceutical Sciences.
4.Review article good manufacturing practices (GМР)
Ariuntsetseg A ; Tserendolgor B
Mongolian Pharmacy and Pharmacology 2020;17(2):39-42
Abstract
A model document of World Health Organization for good manufacturing practices was primarily adopted by some consultants in the field of pharmacy in accordance with the deci- sion of the Twentieth World Health Assembly in 1967. Subsequently, the model document for good manufacturing practices was accepted with the title “Draft requirements for good manufacturing practice in the manufacture and quality control of medicines and pharmaceutical specialties” in the Twenty-First World Health Assembly.
In this review, good manufacturing practices adopted in Mongolia has been compared to those of the United States of America, Peoples Republic of China, Thailand, Indonesia and Cambodia. According to the comparison, the requirements in the good manufacturing practices of Mongolia, including specialists, building, equipment, hygiene, raw materials, documentation, validation, product recall and quality control, have been considered to be similar with those of the countries.
5.Early diagnosis of nephropathy in patients with hypertension
Naran-Ulzii S ; Ariunaa T ; Baigalmaa E ; Ariuntsetseg N ; Enkhtuya J
Mongolian Medical Sciences 2011;172(2):45-49
Background: High blood pressure is both a cause and a complication of chronic kidney disease. As complication, high blood pressure may develop early during course of chronic kidney disease and is associated with adverse outcomes, in particular faster loss of kidney function and development of cardiovascular disease. The purpose of this study is early detection of chronic kidney disease in patients with hypertension by defining the prevalence of microalbuminuria.Methods: The study population consisted of 169 subjects with a hypertension. Individuals were considered to have hypertension if the blood pressure measured greater than 140/90 mmHg or if they were taking blood pressure lowering medications. Microalbuminuria was defined as 20 mg/l or greater. Results: We are presenting data on 169 subjects :male 38 (22.5%) female 131 (77.5%), average age 51.6±0.89 At screening, 14.8% of all participants were smokers, 62.1 % engaged in low levels of physical activity, 72.8% - were having tea with salt (table1). Microalbuminuria and renal failure, as GFR<60 ml/ min/1.73 m2, were documented in 34.3% and 16.6% of subjects, respectively. There is positive correlation between MAU and increasing-range of blood pressure (table2). Correlation was found between albuminuria and GFR(r= -0.2 p<0.01) and serum creatinine(r=0.31 p<0.01) the regression result has shown that GFR is associated with MAU and serum creatinine (table 3).Conclusions:1. In 34.3% of patient with hypertension was found nephropathies with MAU2. Microalbuminuria is increased with decline of GFR and raise of systolic blood pressure. GFR decline is with the raise of age and serum. It is important to implement in clinical practice screening of MAU hypertensive patients.3. In 2/3 of all screened subjects was found 1 and more risk factors for CVD.
6. ENDOMETRIOSIS – CLINICAL PRESENTATION, PROGNOSTIC VALUE OF IMMUNOLOGIC AND CYTOLOGICAL EXAMINATION
Unurjargal D ; Ariuntsetseg A ; Enkhtuvshin U ; Sainkhuu B ; Legshidnyam B ; Dashdemberel B ; Odbaigal T ; Aina K ; Narantuya D ; Enkhbat B ; Ganhuyag B ; Bolorchimeg B
Innovation 2015;9(3):20-24
Endometriosis is described as a chronic inflammatory disease, characterized by endometrial-like tissue, found outside the uterine cavity which cause chronic pelvic pain, infertility,dysmenorrhea. The prevalence of endometriosis is difficult to determine accurately but in asymptomatic women, the prevalence of endometriosis ranges from 2- 22 %, depending on the population studied , in infertile women 20-50 % and in those with pelvic pain, between 40-50% (Balasch, 1996; Eskenazi, 2001; Meuleman, 2009).Endometriosis is found 7-10% of reproductive agewomen and 20-90% in with chronic pelvic pain, infertility cases. Pathogenesis of endometriosis is not yet fully understood but one potential cause of the disease is retrograde menstruation which results in the deposition of endometrial tissue into the peritoneal cavity. Today a composite theory of retrograde menstruation with implantation of endometrial fragments in conjunction with peritoneal factors to stimulate cell growth is the most widely accepted explanation for peritoneal endometriosis. Susceptibility to endometriosis is thought to depend on the complex interaction of genetic, immunologic, hormonal and environmental factors. To determine prevalence and severity of clinical symptoms, compare meta-analysis to changes the clinical value of serum CA-125 and peritoneal fluid cytology in women with endometriosis of Ulaanbaatar city. We had selected total of 60 woman with endometriosis which were registered from January to December 2014 in gynecologic clinic of First Maternity Hospital. The research group registered in questionnaire with 28 questions. During the inspection laboratory analysis of serum CA-125, ultrasound analysis and peritoneal fluid cytology were done. Assessment of pelvic pain by means of a 10-point linear analog scale / pain score/ which provided by International Pain Association. The research result was worked out by prospective method. Average age of patients 33.4±8.9. Pain location: Chronic pelvic pain 30%; Dysmenorrhea 28.3%; Dysparunea 10%; Pain during defecation 6,7%; Without pain -25%. Average level of Serum СА125 was 38.13±20.6. Location of endometriosis: adenomyosis - 8.4%, endometrioma-15% endometriotic lesion at cul de suc 68.3%, rectal involment 1.7%, tubal lesion-3.3%, combined 3,3%. 76.7% of surgery for endometriosis have done by laparoscopy and 23.3% by laparotomy. Ultrasound examination result: endometrioma d=0-2cm-1.7%, d= 3-5cm-36.2%, d=6-8cm-10.3%, d=9cm<-12.1%. Cytology result: Peritoneal fluid contains 75% of erythrocytes, mesothelial cells and it needs to further study.CONCLUSION:Most of patient /58.3%/ had chronic pelvic pain and dysmenorrhea. The severity of pain was significantly improved after operative laparoscopy. /p<0.05%/51,7% of patient had infertility problem.Value of serum CA-125 was higher in study group with large sized and not clear content ovarian endometrioma by ultrasound examination. /p<0.05%/The local environment of peritoneal fluid surrounding the endometriotic implant is immunologically dynamic and links the reproductive and immune systems. Peritoneal factors to stimulate cell growth is the most widely accepted explanation for peritoneal endometriosis. Peritoneal fluid contains a variety of free floating cells, including macrophages, mesothelial cells, lymphocytes, erythrocytes, eosinophils and mast cells. In our cytology results: peritoneal fluid contains 75% of erythrocytes, mesothelial cells.
7.Study of manufacturing technology of tablet formulation from Mana-4
Tserendolgor B ; Ariuntsetseg A ; Byambasuren G ; Ulambayar B ; Altantsetseg A ; Altantuya Ts
Mongolian Pharmacy and Pharmacology 2019;15(2):42-45
Abstract
Mana-4, an herbal medicine, had been used to treat incomplete-mannered and infection-caused hot disease in Mongolian traditional medicine. It has already reported that Mana-4 acts as an anti-inflammation agent, an activator of T and B cells, an immune-modulator and an inducer of cellular proliferation. Moreover, it enhances the immune system and energy level of human body.
It was confirmed that the main active compounds in Mana-4 are inulin and total flavonoids which are effective for many diseases. Drug formulation types are very important to delivery the drugs to the targeted tissues and organs without loss of active ingredients. Total flavonoids in the extract of Mana-4 and granulated Mana-4 was qualitatively evaluated by TLC and yellow-brown spots (Rf was 0.4) were found on TLC plates, indicating that the preparations contained flavonoids. Also, it confirmed that the appropriate extractor of total flavonoids from Mana-4 was 70% of ethanol. In conclusion, the tablet formulation from Mana-4 was successfully prepared and the quality requirements was allowable.
8.Technological study for obtaining an appropriate extract from Stellera Chamaejasme L. and Oxytropis Pseudoglandulosa
Maitsetseg N ; Ariuntsetseg A ; Altantuya Ts ; Ulambayar L ; Altansukh Ts ; Tserendolgor B
Mongolian Pharmacy and Pharmacology 2023;22(1):22-27
Background:
Infections in respiratory systems have spread throughout the world without any restrictions including living places, public issues, and lifestyle. Three main causes of illnesses for the population of cities and rural areas were gastrointestinal diseases, respiratory diseases, and cardiovascular diseases. After investigated some medicinal herbs including Stelleria Chamaejasme L. and Oxytropis Pseudoglandulosa, it has been reported that they had antiinflammatory, analgesic, and wound healing effects. Lozenge formulation has some advantages for treatment application, such as easily absorbed, good bioavailability and ability of diminishing stomach irritation. In this study, we aimed to obtain a suitable extract from Stelleria Chamaejasme L. and Oxytropis Pseudoglandulosa for further lozenge formulation.
Purpose:
To obtain a suitable extract from Stelleria Chamaejasme L. and Oxytropis Pseudoglandulosa, and to conduct qualitative and quantitative studies for some biologically active substances
Materials and methods:
In this study, an aerial part of Stelleria Chamaejasme L. and Oxytropis Pseudoglandulosa were used, and the study was conducted in MUPS. For obtaining a suitable extract, the raw materials were extracted by remaceration, repercolation and circulation methods in 20% and 70% of ethanol and distilled water. The flavonoids and polyphenolic compounds in the extracts were determined by thin layer chromatography. Quantitative analysis for total flavonoids was performed by spectrophotometer.
Results:
According to the result, a yellow spot-on chromatogram was detected in extracted raw materials (Stelleria Chamaejasme L. and Oxytropis Pseudoglandulosa), indicating that flavonoid contained in the extracted solution.
The result was compared to standards of rutin (Rf=0.2) and quercetin (Rf= 0.94). Also, a black, blue spot-on chromatogram was detected in extracted raw materials (Stelleria Chamaejasme L. and Oxytropis Pseudoglandulosa), indicating that polyphenols contained in the extracted solution. The spots were compared to gallic acid as a standard substance. In the quantitative assay of total flavonoids in raw materials, black-green precipitation was revealed after procedure. From this result, remaceration and circulation techniques were suitable to extract the raw materials. Flavonoid content was 3.35±0.04% after using remaceration technique, which indicated that it was more suitable to extract the raw materials.
Conclusions
These results showed that the appropriate extracting solution for Stelleria Chamaejasme L. and Oxytropis Pseudoglandulosa was 70% of ethanol. In this case, 3.35±0.04% of flavonoid was extracted by remaceration technique.
9.Postpartum readmission rate
Odonzul Ts ; Batbold Ts ; Ariuntsetseg J ; Sergelen P ; Hangal Sh ; Ganbold S ; Munkh-Erdene L ; Erkembaatar T
Mongolian Medical Sciences 2020;193(3):28-34
Background:
Postpartum readmission rate has been increasing after both caesarean and vaginal delivery.
Postpartum diseases, in some cases with infection and anemia, result in hospital readmission. Also
it raises the issue associated with maternal hospital’s healthcare quality. There has lack of study
focusing on postpartum readmission. So we will study postpartum readmission rate.
Material and Methods:
112 patients who readmitted in Amgalan maternity hospital in Ulaanbaatar were involved in this study.
We used patient’s medical history to determine risk factors resulted in hospital readmission after
caesarean and vaginal therapy.
Results:
The mean age of women delivered by cesarean was 30.2±7.32 and vaginal delivery’s was 28.3±7.21.
34.8 percent of women who readmitted after vaginal delivery had 1-3 readmission days and 56.5
percent was 4-6 days and 8.7 percent was 7-10 days. Readmission day for women delivered
by caesarean was 1-3 days in 21.2 percent of these, 4-6 days in 56.1 percent and 7-10 days in
19.7 percent. The mean readmission day of women delivered by vaginal delivery was 4.73±1.61
(mean±SD) and the mean of women delivered by caesarean delivery was 5.54±2.34 (mean±SD). In
each category, there had 24.2-28.3 percent cases with lochia. Women who had caesarian delivery
were infected their scar with 24(36.3) cases. Renal urinary system infection had in 12(26.0) women
delivered by vaginal delivery.
Conclusion
58.9 percent of total readmissions cases were caesarean and 41.1 percent was vaginal delivery.
Lochia and renal urinary infection had influence in readmission after vaginal delivery. Also both lochia
and infected wound impacted on postpartum readmission after caesarian delivery.